Dr. White is widely recognized as a leading expert in aging and regenerative medicine. He earned his Ph.D. from the Ansary Stem Cell Institute in the Division of Regenerative Medicine at Cornell University and completed postdoctoral training at the Interdisciplinary Stem Cell Institute at the University of Miami’s Miller School of Medicine, where he published pioneering research on the role of peripheral nerve signaling in cardiac regeneration. Dr. White is the CEO and CSO of Neobiosis, a perinatal regenerative tissue research and manufacturing company, and also serves as CSO for Ways2Well. He is the Vice President and a member of the Board of Directors of the American College of Regenerative Medicine. Additionally, he serves on the scientific advisory boards of the Alliance for Longevity Initiatives (A4Li) and the Healthspan Action Coalition.
The government of the Bahamas appointed Dr. White to the Ethics Committee for the Longevity and Regenerative Therapy Act (LARTA). He is also the founder of the Space-Aging Research Institute (SARI).